The Foundation is currently accepting applications from lupus investigators and student researchers for our Career Development and Student Summer Fellowship grant programs.
Aspreva Founder and CEO to lead the next stage of Aurinia’s development
In a victory for research advocates, on December 13, President Barack Obama signed the 21st Century Cures Act into law.
Fast Track is a process designed to expedite FDA review and get important new drugs to the patient earlier.
Over a year of advocacy efforts have paid off as the bill now moves to the President for signature.
Lupus is the feature of a new publication by the largest non-profit alliance committed to making medical research a national priority.
This week, LFA-supported researchers will share results of a study that could help expedite the delivery of new and safer therapies to people with lupus.
Aurinia Pharmaceuticals announced its plans for a single Phase III clinical trial for voclosporin in the treatment of lupus nephritis.